Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02681042 · ClinicalTrials.gov registry record · NA
Left Atrial Appendage Closure With SentreHeart Lariat® Device
A NA study, sponsored by Baylor Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02681042: Completed NA study, sponsored by Baylor Research Institute.
NCT02681042 is a NA study that has completed, run by Baylor Research Institute. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02681042, a NA study, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The study cohort will consist of up to 50 patients who are candidates for Left Atrial Appendage (LAA) closure in whom oral anticoagulation is contraindicated. Subjects evaluated for left atrial appendage closure will be screened for inclusion and consented prior to their procedure. If the anatomy is favorable for placement of the Lariat® device, the procedure will be performed at one of the participating centers. If anatomy is not favorable, the patient will be excluded from the study and managed using best care practices by his or her physician.
Primary Outcome
The primary aim is to assess the outcome of patients undergoing left atrial appendage ligation or closure with the SentreHeart Lariat® device as a stand-alone procedure at the participating centers
Interventions
- PROCEDURE Left atrial appendage closure
- DEVICE SentreHeart Lariat®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-05-02 |
| Phase | NA |
What the finished NCT02681042 record still lists
NCT02681042 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Left atrial appendage closure is the first listed.
NCT02681042 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02681042 about?
NCT02681042 is a clinical study titled "Left Atrial Appendage Closure With SentreHeart Lariat® Device". The study cohort will consist of up to 50 patients who are candidates for Left Atrial Appendage (LAA) closure in whom oral anticoagulation is contraindicated. Subjects evaluated for left atrial appendage closure will be screened for inclusion and consented prior to their procedure. If the anatomy i...
What is the current status of trial NCT02681042?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2015-03. Estimated completion is 2018-05-02.
What interventions are being tested in trial NCT02681042?
The interventions under investigation include: Left atrial appendage closure (PROCEDURE), SentreHeart Lariat® (DEVICE).
Who is sponsoring clinical trial NCT02681042?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02681042's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia